GNE-3511 is an orally active, bioavailable and brain-permeable dual leucine zipper kinase (DLK) inhibitor with a Ki of 0.5 nM.GNE-3511 can be used in studies related to neurodegenerative diseases.
Molecular Weight:
440.49
Purity:
98.48%
CAS Number:
[1496581-76-0]
Target:
p38 MAPK
* VAT and and shipping costs not included. Errors and price changes excepted